Show Search Form
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health | ||||||||||||
answering dept sort name | Health | ||||||||||||
ddp created |
|
||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Radioisotopes: Imports | ||||||||||||
house id | 2 | ||||||||||||
identifier | HL1104 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 57 | ||||||||||||
question first answered |
|
||||||||||||
question text | Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit. | ||||||||||||
session |
|
||||||||||||
session number | 1 | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL1104 | ||||||||||||
type |
|
||||||||||||
uin | HL1104 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | Ordinary | ||||||||||||
answer |
|
||||||||||||
creator |
|
||||||||||||
publisher |
|
||||||||||||
tabling member |
|
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health | ||||||||||||
answering dept sort name | Health | ||||||||||||
ddp created |
|
||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Nurses: Training | ||||||||||||
house id | 2 | ||||||||||||
identifier | HL1089 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 57 | ||||||||||||
question first answered |
|
||||||||||||
question text | Her Majesty's Government what discussions they have had with (1) the Royal College of Nursing, (2) the Royal College of Midwives, and (3) UNISON, as a consequence of the fall since 2016 reported by UCAS in the number of applications to universities to study for nursing degrees. | ||||||||||||
session |
|
||||||||||||
session number | 1 | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL1089 | ||||||||||||
type |
|
||||||||||||
uin | HL1089 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | Ordinary | ||||||||||||
answer |
|
||||||||||||
creator |
|
||||||||||||
publisher |
|
||||||||||||
tabling member |
|
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
ddp created | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health | ||||||||||||
answering dept sort name | Health | ||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Cancer: Mortality Rates | ||||||||||||
house id | 2 | ||||||||||||
identifier | HL1056 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 57 | ||||||||||||
question first answered |
|
||||||||||||
question text | Her Majesty's Government what is their assessment of the findings by Integrating the Healthcare Enterprise in its report, Comparator report on patient access to cancer medicines in Europe Revisited, that UK five-year survival outcomes for cancer lag behind the European average for nine out of ten cancers. | ||||||||||||
session |
|
||||||||||||
session number | 1 | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL1056 | ||||||||||||
type |
|
||||||||||||
uin | HL1056 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | Ordinary | ||||||||||||
answer |
|
||||||||||||
creator |
|
||||||||||||
publisher |
|
||||||||||||
tabling member |
|
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health | ||||||||||||
answering dept sort name | Health | ||||||||||||
ddp created |
|
||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Nurses: Training | ||||||||||||
house id | 2 | ||||||||||||
identifier | HL1090 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 57 | ||||||||||||
question first answered |
|
||||||||||||
question text | Her Majesty's Government what progress has been made to date in implementing their plan to provide 10,000 additional nursing student places by 2020; and how much additional funding has been provided to universities as part of this plan. | ||||||||||||
session |
|
||||||||||||
session number | 1 | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL1090 | ||||||||||||
type |
|
||||||||||||
uin | HL1090 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | Ordinary | ||||||||||||
answer |
|
||||||||||||
creator |
|
||||||||||||
publisher |
|
||||||||||||
tabling member |
|